Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Osteosarcoma, Advanced”

137 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 137 results

Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)UnknownNCT03163381
What this trial is testing

Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.

Who this might be right for
Osteosarcoma, Advanced
Henan Cancer Hospital 40
Not applicableTemporarily Not AvailableNCT03842865
What this trial is testing

Expanded Access of Vigil in Solid Tumors

Who this might be right for
Solid TumorEwing SarcomaEwing's Tumor Metastatic+5 more
Gradalis, Inc.
Early research (Phase 1)Ended earlyNCT03525392
What this trial is testing

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerGastric Cancer+5 more
Ipsen 14
Early research (Phase 1)Study completedNCT01286987
What this trial is testing

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Who this might be right for
Advanced or Recurrent Solid TumorsBreast NeoplasmsOvarian Cancer, Epithelial+4 more
Pfizer 113
Very early researchActive Not RecruitingNCT04634227
What this trial is testing

Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)

Who this might be right for
SarcomaSoft Tissue SarcomaUnresectable Soft Tissue Sarcoma+2 more
University of Iowa 30
Testing effectiveness (Phase 2)Ended earlyNCT03468075
What this trial is testing

Gemcitabine Plus Ascorbate for Sarcoma in Adults

Who this might be right for
SarcomaSoft Tissue SarcomaUnresectable Soft Tissue Sarcoma+2 more
Mohammed Milhem, MBBS 10
Testing effectiveness (Phase 2)UnknownNCT03242382
What this trial is testing

Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.

Who this might be right for
Soft-tissue SarcomaOsteosarcomaChordoma
Grupo Espanol de Investigacion en Sarcomas 40
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT00027716
What this trial is testing

Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02406781
What this trial is testing

Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial

Who this might be right for
Sarcoma
Institut Bergonié 129
Testing effectiveness (Phase 2)Study completedNCT00949325
What this trial is testing

Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma

Who this might be right for
Sarcoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Testing effectiveness (Phase 2)Study completedNCT01154452
What this trial is testing

Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma

Who this might be right for
Adult Alveolar Soft Part SarcomaAdult AngiosarcomaAdult Desmoplastic Small Round Cell Tumor+32 more
National Cancer Institute (NCI) 78
Not applicableUnknownNCT03919539
What this trial is testing

Epigenetic Biomarker for Advanced Osteosarcoma Using Famitinib and Camrelizumab

Who this might be right for
Drug Resistance to Famitinib and CamrelizumabBiomarkers for Efficacy and Toxicity
Peking University People's Hospital 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03698994
What this trial is testing

Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Ependymal TumorRecurrent Ewing Sarcoma+33 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00474760
What this trial is testing

Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors

Who this might be right for
Sarcoma, Ewing's
Pfizer 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213704
What this trial is testing

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+30 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT00031915
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00062283
What this trial is testing

Alanosine in Treating Patients With Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaPancreatic Cancer+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06074692
What this trial is testing

PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)

Who this might be right for
SarcomaSarcoma,Soft TissueSarcoma of Bone
Ruijin Hospital 86
Load More Results